A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies - Deeken, John F.; Slack, Rebecca; Weiss, Glen J.; Ramanathan, Ramesh K.; Pishvaian, Michael J.; Hwang, Jimmy; Lewandowski, Karen; Subramaniam, Deepa; He, Aiwu Ruth; Cotarla, Ion; Rahman, Aquilur; Marshall, John L. (Cancer chemotherapy and pharmacology, 2013)
Keywords: Adult; Aged; Antineoplastic agents; Antineoplastic Agents, Phytogenic - administration & dosage; Antineoplastic Agents, Phytogenic - therapeutic use; Area Under Curve; Biological and medical sciences; Cancer Research; Cohort Studies; Drug Administration Schedule; Drug Carriers; Drug Compounding; Drug Resistance, Neoplasm; Excipients; Female; Freeze Drying; Half-Life; Humans; Infusions, Intravenous; Liposomes; Male; Maximum Tolerated Dose; Medical sciences; Medicine; Medicine & Public Health; Middle Aged; Multiple tumors. Solid tumors. Tumors in childhood (general aspects); Neoplasms - drug therapy; Oncology; Original Article; Pharmacology. Drug treatments; Pharmacology/Toxicology; Taxoids - administration & dosage; Taxoids - therapeutic use; Treatment Outcome; Tumors; Clinical trial; Phase I; Liposomes; Docetaxel; Antineoplastic agent; Human; Solid tumor; Toxicity; Liposome; Drug carrier; Malignancy; Malignant tumor; Treatment; Taxane derivatives; Phase I trial; Advanced stage; Pharmacokinetics; Antimitotic; Cancer